Home › Cardiovascular Disease › Pennsylvania › Lancaster
Cardiovascular Disease clinical trials in Lancaster, PA
5 studies for Cardiovascular Disease are looking for participants at sites in and around Lancaster (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ELEVATE-HFpEF Clinical Study
Recruiting
- Lancaster General Hospital, Lancaster
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Penn Lancaster General Health Research Institute, Lancaster
Product Surveillance Registry
RecruitingObservational study
- Lancaster, Lancaster
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Lancaster General Health, Lancaster
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Penn Medicine Lancaster General Health, Lancaster
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Lancaster
- Non-Small Cell Lung Cancer7 studies
- Heart Failure5 studies
- Prostate Cancer4 studies
- Metastatic Cancer4 studies
- Breast Cancer4 studies
- Lung Cancer3 studies
- Bladder Cancer3 studies
- Amblyopia3 studies
- Heart Diseases3 studies
- Non-Muscle Invasive Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.